• Home
  • Use of Germline BRCA Testing in Patients With Ovarian Cancer and Commercial Insurance.

Use of Germline BRCA Testing in Patients With Ovarian Cancer and Commercial Insurance.

Author List
Cham S, Landrum MB, Keating NL, Armstrong J, Wright AA
Publication
JAMA network open
Publication ID (Profile URL)
https://researcherprofiles.org/profile/338615541
Publication Year
2022
PubMed ID
35015069
Publication Title
Cham S, Landrum MB, Keating NL, Armstrong J, Wright AA. Use of Germline BRCA Testing in Patients With Ovarian Cancer and Commercial Insurance. JAMA Netw Open. 2022 01 04; 5(1):e2142703.